PRESCRIPTION DRUG PRICING REDUCTION ACT; Congressional Record Vol. 166, No. 102
(Senate - June 02, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page S2635]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                PRESCRIPTION DRUG PRICING REDUCTION ACT

  Mr. GRASSLEY. Madam President, the virus pandemic is disrupting our 
daily lives in unimaginable ways. The National Institutes of Health is 
working with a private sector biotech company and has already begun 
early-stage human trials for a potential vaccine, so there is hope on 
the horizon. However, the soaring prices of prescription drugs are 
making lifesaving treatments and cures simply unaffordable for many 
Americans.
  This pandemic made clear two issues: Americans urgently want a cure, 
and when lifesaving therapies and cures come to the market, Americans 
must be able to afford them when their providers prescribe them.
  My bipartisan Prescription Drug Pricing Reduction Act is needed now 
more than ever.
  I yield the floor.

                          ____________________